SCHEMBL6925049

SCHEMBL6925049

COC(=O)c1ccc2[nH]c3c(=O)[nH]cnc3c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 2/20 0.52
DYRK1A Q13627 1/20 0.50
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KIF11 P52732 2/20 0.45
PARP1 P09874 4/20 0.45
FTO Q9C0B1 1/20 0.44
CREBBP Q92793 1/20 0.44
CYP3A4 P08684 1/20 0.44
ABCC1 P33527 1/20 0.44
CSNK2A1 P68400 1/20 0.44
GSK3B P49841 1/20 0.43
MET P08581 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826816 0.79 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10DYRK1A
SCHEMBL6828575 0.78 KDM4E (0.63) KDM4EALDH1A1HPGDHSD17B10DYRK1A
SCHEMBL31322401 0.77 KDM4E (0.55) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL263292 0.76 SLC2A1 (0.71) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL29698253 0.76 SLC2A1 (0.71) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL28063129 0.74 KIF11 (0.70) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL31618251 0.74 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL17396507 0.74 RXFP1 (0.55) KDM4EALDH1A1HPGDDYRK1AMEN1
SCHEMBL31067306 0.73 PARP1 (0.56) KDM4EALDH1A1HSD17B10DYRK1ARAB9A
SCHEMBL265032 0.73 PARP1 (0.56) KDM4EALDH1A1HSD17B10DYRK1ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004111052-A1 PYRROLOPYRIMIDINE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE (MDR) XENOVA LIMITED (GB) 2004-12-23 WO disclosed